Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-02 Sale |
2023-11-06 4:56 pm |
Applied Therapeutics Inc. | APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. Alexandria Equities No. 7 LLC Alexandria Venture Investments LLC 10% Owner |
247,258 | $2.3142 | $572,204 | 6,359,054 (Indirect) |
View |
| 2023-10-31 Sale |
2023-11-02 4:44 pm |
Applied Therapeutics Inc. | APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. Alexandria Venture Investments LLC Alexandria Equities No. 7 LLC 10% Owner |
327,742 | $2.3836 | $781,221 | 6,606,312 (Indirect) |
View |
| 2023-09-27 Sale |
2023-09-29 8:03 pm |
Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner |
115,632 | $2.7 | $312,206 | 6,930,846 (Indirect Direct) |
View |
| 2023-09-27 Sale |
2023-09-29 8:02 pm |
Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer |
10,932 | $2.7 | $29,516 | 693,924 (Direct) |
View |
| 2023-09-27 Sale |
2023-09-29 8:02 pm |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
9,720 | $2.7 | $26,244 | 382,755 (Direct) |
View |
| 2023-01-11 Sale |
2023-01-13 4:34 pm |
Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner |
15,870 | $0.91 | $14,442 | 7,046,478 (Indirect Direct) |
View |
| 2023-01-11 Sale |
2023-01-13 4:32 pm |
Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer |
6,053 | $0.91 | $5,508 | 704,856 (Direct) |
View |
| 2023-01-11 Sale |
2023-01-13 4:30 pm |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
4,495 | $0.91 | $4,090 | 392,475 (Direct) |
View |
| 2022-10-14 Purchase |
2022-10-14 5:41 pm |
Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner |
50,000 | $0.645 | $32,250 | 5,097,986 (Indirect Direct) |
View |
| 2022-10-13 Purchase |
2022-10-13 6:17 pm |
Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner |
73,256 | $0.5582 | $40,891 | 5,047,986 (Indirect Direct) |
View |
| 2022-10-12 Purchase |
2022-10-12 8:51 pm |
Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner |
38,153 | $0.5227 | $19,943 | 4,974,730 (Indirect Direct) |
View |
| 2022-06-27 Purchase |
2022-06-29 4:37 pm |
Applied Therapeutics Inc. | APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. Alexandria Venture Investments LLC Alexandria Equities No. 7 LLC 10% Owner |
3,500,000 | $1 | $3,500,000 | 11,055,077 (Indirect) |
View |
| 2022-05-16 Sale |
2022-05-18 9:03 pm |
Applied Therapeutics Inc. | APLT | Mahadevan Chids See Remarks |
905 | $1.65 | $1,493 | 9,800 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-10-12 Other |
2023-10-16 7:17 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. Alexandria Venture Investments LLC Alexandria Equities No. 7 LLC 10% Owner |
2,830,000 | $0 | 5,478,977 (Indirect) |
View |
| 2023-09-15 Exercise |
2023-09-19 8:08 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director |
12,375 | $1.05 | 453,414 (Direct) |
View |
| 2023-09-15 Exercise |
2023-09-19 8:08 pm |
N/A 2032-06-02 |
Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director |
12,375 | $0 | 453,414 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:03 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | SKYLER JAY S Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:03 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director |
20,000 | $0 | 441,039 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:02 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Lerner Teena Director |
20,000 | $0 | 60,422 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:02 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Kanter Stacy J. Director |
20,000 | $0 | 33,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:01 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. Director |
20,000 | $0 | 37,148 (Direct) |
View |
| 2023-01-11 Option Award |
2023-01-13 4:34 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner |
1,964,362 | $0 | 7,046,478 (Direct) |
View |
| 2023-01-11 Option Award |
2023-01-13 4:32 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer |
550,000 | $0 | 704,856 (Direct) |
View |
| 2023-01-11 Option Award |
2023-01-13 4:30 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
300,000 | $0 | 392,475 (Direct) |
View |
| 2022-11-15 Option Award |
2022-11-17 9:31 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Ortega Steven A. Principal Accounting Officer |
40,000 | $0 | 55,404 (Direct) |
View |
| 2021-04-14 Exercise(A) |
2022-09-16 9:02 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director |
35,911 | $4.7 | 74,824 (Indirect) |
View |
| 2021-04-14 Exercise(A) |
2022-09-16 9:02 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director |
13,071 | $10 | 74,824 (Indirect) |
View |
| 2021-04-14 Exercise(A) |
2022-09-16 9:02 pm |
N/A 2029-05-12 |
Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director |
13,071 | $0 | 74,824 (Direct) |
View |
| 2022-09-14 Exercise |
2022-09-16 9:01 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director |
38,244 | $1.05 | 433,414 (Direct) |
View |
| 2022-09-14 Exercise |
2022-09-16 9:01 pm |
N/A 2029-05-12 |
Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director |
38,244 | $0 | 433,414 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 9:21 pm |
N/A 2032-06-02 |
Applied Therapeutics Inc. | APLT | SKYLER JAY S Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 9:21 pm |
N/A 2032-06-02 |
Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 9:20 pm |
N/A 2032-06-02 |
Applied Therapeutics Inc. | APLT | Lerner Teena Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 9:20 pm |
N/A 2032-06-02 |
Applied Therapeutics Inc. | APLT | Kanter Stacy J. Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 9:19 pm |
N/A 2032-06-02 |
Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2022-04-13 Option Award |
2022-04-15 7:10 pm |
N/A 2032-04-13 |
Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-04-13 Option Award |
2022-04-15 7:09 pm |
N/A 2032-04-13 |
Applied Therapeutics Inc. | APLT | Ortega Steven A. Principal Accounting Officer |
13,756 | $0 | 26,079 (Direct) |
View |